Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KALV
3576
DELISTED
KalVista Pharmaceuticals
KALV
| $153K | ﹤0.01% |
12,965
-8,990
| -41% | -$105K |
|
3577
Oppenheimer Holdings
OPY
$1.2B
| $152K | ﹤0.01% |
3,173
-2,924
| -48% | -$125K |
|
3578
Valens Semiconductor
VLN
$188M
| $152K | ﹤0.01% |
47,581
| – | – |
|
3579
Grayscale Bitcoin Trust
GBTC
$9.76B
| $152K | ﹤0.01% |
3,155
| – | – |
|
3580
Comp X International
CIX
$371M
| $152K | ﹤0.01% |
6,150
-532
| -8% | -$14.8K |
|
3581
QuickLogic
QUIK
$257M
| $152K | ﹤0.01% |
+14,597
| New | +$184K |
|
3582
Imperial Oil
IMO
$60.4B
| $152K | ﹤0.01% |
2,221
-1,249
| -36% | -$86K |
|
3583
Global X FinTech ETF
FINX
$170M
| $151K | ﹤0.01% |
6,020
| – | – |
|
3584
MaxCyte
MXCT
$126M
| $151K | ﹤0.01% |
38,609
-40,623
| -51% | -$175K |
|
|
SHYF
3585
DELISTED
The Shyft Group
SHYF
| $151K | ﹤0.01% |
12,760
-51,272
| -80% | -$616K |
|
|
TRUE
3586
DELISTED
TrueCar
TRUE
| $151K | ﹤0.01% |
48,317
-32,137
| -40% | -$94.1K |
|
3587
Sinclair Inc
SBGI
$1.03B
| $151K | ﹤0.01% |
11,342
-18,245
| -62% | -$233K |
|
|
PSTX
3588
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $151K | ﹤0.01% |
51,776
-23,569
| -31% | -$64.5K |
|
3589
CryoPort
CYRX
$762M
| $151K | ﹤0.01% |
21,835
-18,304
| -46% | -$247K |
|
3590
CNB Financial Corp
CCNE
$1.03B
| $150K | ﹤0.01% |
7,346
-7,257
| -50% | -$141K |
|
3591
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34.2B
| $150K | ﹤0.01% |
2,385
| – | – |
|
3592
Star Bulk Carriers
SBLK
$3.22B
| $150K | ﹤0.01% |
6,141
+6,084
| +10,674% | +$151K |
|
3593
Velocity Financial
VEL
$729M
| $149K | ﹤0.01% |
8,333
-2,989
| -26% | -$52.7K |
|
3594
Arbutus Biopharma
ABUS
$915M
| $148K | ﹤0.01% |
48,034
-41,152
| -46% | -$123K |
|
3595
Orange County Bancorp
OBT
$518M
| $148K | ﹤0.01% |
5,604
-3,456
| -38% | -$81.3K |
|
3596
Ouster
OUST
$2.92B
| $148K | ﹤0.01% |
15,063
-19,211
| -56% | -$194K |
|
3597
Cardlytics
CDLX
$21.5M
| $147K | ﹤0.01% |
1,791
-1,418
| -44% | -$153K |
|
3598
Theravance Biopharma
TBPH
$877M
| $146K | ﹤0.01% |
17,264
-27,747
| -62% | -$250K |
|
|
ARIS
3599
DELISTED
Aris Water Solutions
ARIS
| $146K | ﹤0.01% |
9,312
-11,572
| -55% | -$173K |
|
|
HDSN
3600
Hudson Technologies
HDSN
$235M
| $145K | ﹤0.01% |
16,472
-22,516
| -58% | -$218K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.